Literature DB >> 30855749

Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis.

Hervé Bachelez1, Siew-Eng Choon2, Slaheddine Marrakchi3, A David Burden4, Tsen-Fang Tsai5, Akimichi Morita6, Hamida Turki3, David B Hall7, Michael Shear8, Patrick Baum8, Steven J Padula9, Christian Thoma8.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30855749     DOI: 10.1056/NEJMc1811317

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  55 in total

1.  Updates in Psoriasis Management: Based on selected presentations from Maui Derm 2020, January 25-29, 2020, Maui, Hawaii.

Authors:  Jo Ann Lequang
Journal:  J Clin Aesthet Dermatol       Date:  2020-07-01

2.  Epicutaneous Staphylococcus aureus induces IL-36 to enhance IgE production and ensuing allergic disease.

Authors:  Garrett J Patrick; Haiyun Liu; Martin P Alphonse; Dustin A Dikeman; Christine Youn; Jack C Otterson; Yu Wang; Advaitaa Ravipati; Momina Mazhar; George Denny; Roger V Ortines; Emily Zhang; Robert J Miller; Carly A Dillen; Qi Liu; Sabrina J Nolan; Kristine Nguyen; LeeAnn Marcello; Danh C Do; Eric M Wier; Yan Zhang; Gary Caviness; Alexander C Klimowicz; Diane V Mierz; Jay S Fine; Guangping Sun; Raphaela Goldbach-Mansky; Alina I Marusina; Alexander A Merleev; Emanual Maverakis; Luis A Garza; Joshua D Milner; Peisong Gao; Meera Ramanujam; Ernest L Raymond; Nathan K Archer; Lloyd S Miller
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

3.  When bugs and drugs conspire: driving acneiform skin toxicity.

Authors:  Allison C Billi; Mrinal K Sarkar; Johann E Gudjonsson
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

4.  Progression of acute-to-chronic atopic dermatitis is associated with quantitative rather than qualitative changes in cytokine responses.

Authors:  Lam C Tsoi; Elke Rodriguez; Dora Stölzl; Ulrike Wehkamp; Jingru Sun; Sascha Gerdes; Mrinal K Sarkar; Matthias Hübenthal; Chang Zeng; Ranjitha Uppala; Xianying Xing; Frederieke Thielking; Allison C Billi; William R Swindell; Alanna Shefler; Jiahan Chen; Matthew T Patrick; Paul W Harms; J Michelle Kahlenberg; Bethany E Perez White; Emanual Maverakis; Johann E Gudjonsson; Stephan Weidinger
Journal:  J Allergy Clin Immunol       Date:  2019-12-28       Impact factor: 10.793

Review 5.  Interleukin-36: Structure, Signaling and Function.

Authors:  Li Zhou; Viktor Todorovic
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Oxidized Lipids and Lipoprotein Dysfunction in Psoriasis.

Authors:  Alexander V Sorokin; Alan T Remaley; Nehal N Mehta
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2020-08-26

7.  Psoriasis: a brief overview.

Authors:  Antony Raharja; Satveer K Mahil; Jonathan N Barker
Journal:  Clin Med (Lond)       Date:  2021-05       Impact factor: 2.659

Review 8.  IL-36 in chronic inflammation and fibrosis - bridging the gap?

Authors:  Michael Elias; Shuai Zhao; Hongnga T Le; Jie Wang; Markus F Neurath; Clemens Neufert; Claudio Fiocchi; Florian Rieder
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

Review 9.  "Autoinflammatory psoriasis"-genetics and biology of pustular psoriasis.

Authors:  Ranjitha Uppala; Lam C Tsoi; Paul W Harms; Bo Wang; Allison C Billi; Emanual Maverakis; J Michelle Kahlenberg; Nicole L Ward; Johann E Gudjonsson
Journal:  Cell Mol Immunol       Date:  2020-08-19       Impact factor: 11.530

Review 10.  The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19?

Authors:  Xiaofang Wang; Panpan Yi; Yuejin Liang
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.